Navigation Links
Nobel Laureate to Join Grove Instruments Board of Directors
Date:12/5/2011

WORCESTER, Mass., Dec. 5, 2011 /PRNewswire/ -- Grove Instruments, Inc., a medical device company based in Worcester, MA, developing the world's first noninvasive glucometer today announced that Craig Mello, Ph.D. is joining the Board of Directors.  Dr. Mello is a Howard Hughes Medical Institute Investigator and the Blais University Chair of Molecular Medicine and Co-Director of the RNA Therapeutics Institute at the University of Massachusetts School of Medicine.  Dr. Mello's pioneering research on RNA inhibition (RNAi), in collaboration with Dr. Andrew Fire, has been recognized with numerous prestigious awards culminating with the 2006 Nobel Prize in Physiology or Medicine. "We are building a world class medical technology company and the addition of Dr. Mello to our Board is another step in our continuing quest for excellence at every level," said Arthur Combs, CEO of Grove.

Dr. Mello's renown in the scientific community is equaled only by his dedication to the care of people with diabetes.  His passion and commitment for diabetes care emanate from a deeply personal experience raising a child with type 1 diabetes.  "Experiencing the 24-hour-a-day every day nature of this disease, really makes you appreciate the tremendous potential benefit of Grove's technology," says Mello.  After 2 years as an Advisor to the Company Dr. Mello decided, "I wanted more involvement – an opportunity to make a bigger impact on the success of the Company and its technology."

"Having a man of science with Dr. Mello's credentials and gravitas is just fantastic for the Company," noted Dr. Paul Lock, career diabetologist and longest seated Board member.  Dr. Robert Peura, Grove Co-founder and father of two children with type 1 diabetes, said, "This is just terrific! I know how powerful it will be to have Craig join us – I know he truly understands the needs of children with diabetes, and how Grove can help."

"This has been a landmark year for Grove – technologically and organizationally.  Having Dr. Mello join us is the perfect culmination to a great year, and a huge head start on the future," said Combs of Grove's Board being enhanced by the Nobel Laureate.

About Grove Instruments

Grove Instruments, Inc. is a privately held pre-market medical device company developing the world's first noninvasive glucometer with the potential to exceed the ISO standard for blood glucose meters.  Grove's patented technology is based on the seminal concept of the Optical Bridge and is unique among all NIR spectroscopic approaches to noninvasive blood glucose determination.  The Company has been recognized for its innovation, technology development and clinical results on 10 separate occasions by the NIH NIDDK with funded SBIR Grants. In 2011, Grove was also recognized by the Massachusetts Life Sciences Center with an Accelerator Award – one of only 4 recipients out of all Boston-area life sciences companies applying in that round.  For more information see www.groveinstruments.com.


'/>"/>
SOURCE Grove Instruments, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elsevier Honors the 2011 Nobel Laureates
2. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
3. Live Coverage of 2011 Nobel Prize Announcements and Exclusive Content on Nobelprize.org
4. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
5. Thomson Reuters Predicts Nobel Laureates
6. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
7. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
8. Nobel Prize-Winning Discovery
9. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
10. Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
11. Laureates Electronic Submission Gateway Approved
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... South Korea , Oct. 4, 2017  South ... its next-generation CPR training aide "cprCUBE" on Kickstarter. The ... chest compression during cardiac arrests with better efficiency compared ... It also offers real-time feedback on efficacy of the ... The crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):